|
DDX1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.33609789898514E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.30410005017012E-09 |
| Normal-vs-Stage2 |
3.754400E-04 |
| Normal-vs-Stage3 |
8.9045992801573E-11 |
| Normal-vs-Stage4 |
2.53697063357095E-12 |
| Stage1-vs-Stage2 |
2.910000E-01 |
| Stage1-vs-Stage3 |
1.157000E-01 |
| Stage1-vs-Stage4 |
1.116140E-03 |
| Stage2-vs-Stage3 |
4.768400E-02 |
| Stage2-vs-Stage4 |
3.103800E-03 |
| Stage3-vs-Stage4 |
1.131040E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.29329880138584E-12 |
| Normal-vs-AfricanAmerican |
8.779000E-04 |
| Normal-vs-Asian |
2.15939999999026E-05 |
| Caucasian-vs-AfricanAmerican |
2.506600E-01 |
| Caucasian-vs-Asian |
2.165200E-01 |
| AfricanAmerican-vs-Asian |
8.534400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.67800054038526E-10 |
| Normal-vs-Female |
5.95979932072055E-11 |
| Male-vs-Female |
5.731200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.59909996355623E-09 |
| Normal-vs-Age(41-60Yrs) |
3.23320004103067E-09 |
| Normal-vs-Age(61-80Yrs) |
1.22709953309652E-10 |
| Normal-vs-Age(81-100Yrs) |
6.258100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.866000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.504000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.980400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.080800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.315800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.103200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.960140E-02 |
| Classical-VS-Follicular |
8.075600E-01 |
| Classical-VS-Other |
6.535400E-01 |
| Classical-VS-Normal |
1.24450005856147E-10 |
| Tall-VS-Follicular |
1.834030E-02 |
| Tall-VS-Other |
5.920200E-01 |
| Tall-VS-Normal |
2.06670003333187E-09 |
| Follicular-VS-Other |
6.736000E-01 |
| Follicular-VS-Normal |
1.53854999999092E-05 |
| Other-VS-Normal |
7.464700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.00809999131957E-09 |
| Normal-vs-N1 |
1.29799948567211E-10 |
| N0-vs-N1 |
4.398500E-02 |
|
|
